ArticleJournal of medicinal chemistry2026
Expanding Addressable KRAS Mutations through the Structure- and Property-Based Design of Dual-State (GDP/GTP), Reversible Pan-KRAS Inhibitors.
Ryan P Wurz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.